Temporary Halt on Medicare Enrollments to Combat Fraud

The Trump administration plans to temporarily halt new enrollees from joining Medicare as home health and hospice providers, effective Wednesday. This decision arises due to significant fraud concerns within the Medicare system, which provides essential services to elderly and disabled U.S. citizens. This nationwide moratorium is spearheaded by Vice President JD Vance's anti-fraud task force aiming to mitigate healthcare fraud.

States like California and Minnesota, led by Democrats, have shown insufficient fraud prevention efforts. Meanwhile, increased scrutiny was observed in Georgia and Ohio's hospice sectors last year. A spokesperson for Vance noted that fraudulent activities have persisted for too long, and the task force is determined to eliminate these deceptive practices effectively.

This decision, set for a public announcement alongside other policy changes, will enable the Centers for Medicare & Medicaid Services to thoroughly assess spending in hospice and home health services. This pause addresses concerns over the swift establishment of deceitful service providers in these sectors, prompting additional regulatory compliance requirements.

In 2024, Medicare data showed hospice services were provided to 1.8 million beneficiaries, costing $28.3 billion, while home healthcare services catered to 2.7 million beneficiaries at a cost of $16 billion. Vance's task force has specifically targeted hospice fraud in California, where a 2022 state audit revealed significant fraudulent activities due to inadequate oversight mechanisms.

Industry responses vary, with some organizations supporting the enrollment freeze while others caution against measures that could restrict patient access to care. Notably, major players like BrightSpring Health Services, Matrix Medical Network, and UnitedHealth contribute significantly to the U.S. home health market. In hospice services, VITAS Healthcare, a Chemed Corporation subsidiary, stands as a leader. Fraudulent activities continue to escalate costs across the healthcare spectrum, with estimates suggesting tens of billions lost annually, impacting patients and employers alike.

The current administration's anti-fraud initiatives extend beyond home health and hospice sectors, targeting areas like durable medical equipment. A notable measure includes a Medicare enrollment freeze on equipment suppliers, enacted in February. This anti-fraud campaign initialed in Minnesota also saw withholding of $259 million in Medicaid funds, alongside a crackdown on a $250 million fraud scandal in a child nutrition program, ultimately leading to heightened immigration enforcement.